Not sure what is the difference between Plan A and C. But the investment horizon should be set in medium/long term (2 years?) with the hope of improved sales, US partnership deal and future approvals.
The short term cash grab (Plan B) is just wishful thinking. It is a pharmaceutical company with talent employees and ambitious managers, not an ATM. Plus the NovaQuest deal made PXS an unattractive takeover target, since the future revenue will need to be shared.
cash 2x market cap, page-38
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.92M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 104121 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 99980 | 1 |
View Market Depth
| Last trade - 10.09am 15/11/2024 (20 minute delay) ? |
| SNT (ASX) Chart |
Day chart unavailable